SCHEMBL95880

SCHEMBL95880

O=[C]c1cccc2c1CCCO2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.36
MTNR1B P49286 1/20 0.36
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
HTR2A P28223 7/20 0.33
HTR2C P28335 7/20 0.33
HTR2B P41595 6/20 0.33
HTR1A P08908 5/20 0.33
HTR1D P28221 4/20 0.33
LMNA P02545 2/20 0.32
CRHBP P24387 2/20 0.32
CRHR2 Q13324 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
ACHE P22303 2/20 0.31
CLK1 P49759 1/20 0.31
DYRK1A Q13627 1/20 0.31
DYRK1B Q9Y463 1/20 0.31
DRD2 P14416 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17240293 0.89 ITGB2 (0.38) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL30289551 0.84 ITGB2 (0.37) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL21224311 0.84 ITGB2 (0.37) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL436160 0.73 MAP3K14 (0.46) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL5845014 0.73 KDM4E (0.39) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL97610 0.72 KDM4E (0.45) MTNR1AITGB2ICAM1ITGALLMNA
SCHEMBL139722 0.72 ACHE (0.45) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL20870690 0.72 ITGB2 (0.39) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL6584559 0.72 ITGB2 (0.39) MTNR1AMTNR1BITGB2ICAM1ITGAL
SCHEMBL14304553 0.72 ITGB2 (0.39) MTNR1AMTNR1BITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB MTNR1A 1110/4885MTNR1B 732/4885ITGB2 3777/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 MTNR1A 460/4885MTNR1B 930/4885ITGB2 2744/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 MTNR1A 460/4885MTNR1B 930/4885ITGB2 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.